Bone Marrow Failure Scientific Symposium
The first AA&MDSIF Bone Marrow Failure Scientific Symposium was held in October 2005 in Washington, DC. A host of accomplished speakers from around the globe presented at this two-day symposium dedicated to bone marrow failure syndromes.
Major objectives of the Symposium were to compare and to contrast the pathophysiology, epidemiology, and treatments for these historically diverse syndromes that are now increasingly recognized to share both common mechanisms of disease and responsiveness to therapy.
Attendees, who traveled from more than fifteen countries, were stimulated to contribute collectively about development of new ideas through information exchange, animated discussions, and critical thought. The meeting also served as an inspiration for the young researchers in attendance.
 |
 |
The Bone Marrow Failure Scientific Symposium was sponsored by the National Institutes of Health: Office of Rare Diseases; National Cancer Institute; and the National Heart, Lung and Blood Institute. The symposium was organized by the AA&MDSIF under the leadership of Marilyn Baker, Executive Director, and under the scientific direction of Jaroslaw Maciejewski, MD, PhD of the Cleveland Clinic Foundation, Taussig Cancer Center and Neal Young, MD of the National Heart, Lung and Blood Institute; it is an excellent example of tripartite collaboration among government, academia, and pharmaceutical companies with special interest in these diseases and their amelioration.
Symposium Summary and Abstracts
The International Bone Marrow Failure Scientific Symposium: Summary and Abstracts (Washington, DC: October 17-19, 2005) report provides a three-part summation of each presentation, including a brief summary statement, a more detailed description written in lay language, and the presenter's abstract.
It is therefore with great pleasure that the AA&MDSIF announces the Second International Bone Marrow Failure Scientific Symposium tentatively scheduled for late 2008. Please join us to be automatically notified about the next symposium and to get regular updates from the AA&MDSIF.
----
This activity was planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of American Society of Hematology and Aplastic Anemia & MDS International Foundation, Inc. The American Society of Hematology is accredited by the ACCME to provide continuing medical education for physicians. ASH designated this educational activity for a maximum of 11.5 Category 1 credits toward the AMA Physician's Recognition Award.
